Is There a Carbapenem MIC Cutoff Value That Distinguishes Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem Non-Susceptible Pseudomonas and Acinetobacter Isolates?

Infect Control Hosp Epidemiol. 2017 Nov;38(11):1378-1379. doi: 10.1017/ice.2017.210. Epub 2017 Oct 2.

Authors

Pranita D Tamma¹, Ruibin Wang², Shawna Lewis³, Belita N A Opene³, Patricia J Simner³

Affiliations

¹ 1Division of Infectious Diseases Department of Pediatrics,Johns Hopkins University School of Medicine,Baltimore,Maryland.
² 2Department of Epidemiology,Johns Hopkins Bloomberg School of Public Health,Baltimore,Maryland.
³ 3Department of Pathology,Johns Hopkins University School of Medicine,Baltimore,Maryland.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Academic Medical Centers
Acinetobacter
Acinetobacter Infections / diagnosis
Acinetobacter Infections / drug therapy
Acinetobacter baumannii / drug effects*
Acinetobacter baumannii / isolation & purification
Acinetobacter baumannii / metabolism
Anti-Bacterial Agents / pharmacology*
Bacterial Proteins / genetics
Bacterial Proteins / isolation & purification
Bacterial Proteins / metabolism*
Carbapenems / pharmacology
Centers for Disease Control and Prevention, U.S.
Drug Resistance, Microbial
Humans
Imipenem / pharmacology*
Maryland
Meropenem
Microbial Sensitivity Tests
Pseudomonas
Pseudomonas Infections / diagnosis
Pseudomonas Infections / drug therapy
Pseudomonas aeruginosa / drug effects*
Pseudomonas aeruginosa / isolation & purification
Pseudomonas aeruginosa / metabolism
ROC Curve
Sensitivity and Specificity
Thienamycins / pharmacology*
United States
beta-Lactamases / genetics
beta-Lactamases / isolation & purification
beta-Lactamases / metabolism*

Substances

Anti-Bacterial Agents
Bacterial Proteins
Carbapenems
Thienamycins
Imipenem
beta-Lactamases
carbapenemase
Meropenem

Grants and funding